Medicine
Candesartan cilexetil 4 mg tablet
Candesartan cilexetil 4 mg tablet is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Key facts
- Active ingredient (INN)
- Candesartan cilexetil
- Brand
- Sold under the generic name
- Strength
- 4 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 90 tablets, 1000 tablets and 15 more
- Manufacturers
- Alembic PharmaceuticalsIndiaMacleods PharmaceuticalsIndiaViona PharmaceuticalsIndiaZydus LifesciencesIndiaMylan PharmaceuticalsANI PharmaceuticalsGolden State Medical Supply
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 4 June 1998
- Identifiers
- RxCUI 153822, 153823, 577776 +1DailyMed set ID d5b43fa0-6678-4219-99f1-10d273d49baf, 8a515af5-bd53-43f1-b40a-aa0f332bc2ab, 9da86c48-5911-4512-8c71-eca4a6418cf6 +5NDC 46708-341, 62332-341, 72578-157 +5Application ANDA210302, ANDA091390, NDA020838 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet in 1 bottle | 46708-341-30 | Alembic PharmaceuticalsIndia | 5 December 2018 |
| 90 tablet in 1 bottle | 46708-341-90 | Alembic PharmaceuticalsIndia | 5 December 2018 |
| 1000 tablet in 1 bottle | 46708-341-91 | Alembic PharmaceuticalsIndia | 5 December 2018 |
| 30 tablet in 1 bottle | 62332-341-30 | Alembic PharmaceuticalsIndia | 5 December 2018 |
| 90 tablet in 1 bottle | 62332-341-90 | Alembic PharmaceuticalsIndia | 5 December 2018 |
| 1000 tablet in 1 bottle | 62332-341-91 | Alembic PharmaceuticalsIndia | 5 December 2018 |
| 30 tablet in 1 container | 33342-114-07 | Macleods PharmaceuticalsIndia | 6 December 2016 |
| 90 tablet in 1 container | 33342-114-10 | Macleods PharmaceuticalsIndia | 6 December 2016 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 33342-114-12 | Macleods PharmaceuticalsIndia | 6 December 2016 |
| 300 tablet in 1 container | 33342-114-51 | Macleods PharmaceuticalsIndia | 6 December 2016 |
| 30 tablet in 1 bottle | 72578-157-06 | Viona PharmaceuticalsIndia | 7 September 2026 |
| 90 tablet in 1 bottle | 72578-157-16 | Viona PharmaceuticalsIndia | 7 September 2026 |
| 30 tablet in 1 bottle | 70771-1204-3 | Zydus LifesciencesIndia | 22 February 2018 |
| 90 tablet in 1 bottle | 70771-1204-9 | Zydus LifesciencesIndia | 22 February 2018 |
| 50000 tablet in 1 box | 62559-686-99 | ANI Pharmaceuticals | 15 March 2024 |
| 90 tablet in 1 bottle, plastic | 0378-3224-77 | Mylan Pharmaceuticals | 6 January 2020 |
| 30 tablet in 1 bottle, plastic | 0378-3224-93 | Mylan Pharmaceuticals | 6 January 2020 |
| 90 tablet in 1 bottle, plastic | 51407-882-90 | Golden State Medical Supply | 1 April 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 4 June 1998 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Candesartan cilexetil 4 mg tablet.
Other strengths and forms of Candesartan cilexetil
Clinical summary
Candesartan cilexetil is an angiotensin 2 receptor blocker indicated for treatment of hypertension in adults and children 1 to < 17 years of age, to lower blood pressure, among other approved uses. MedsAcross supplies Candesartan cilexetil for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Candesartan cilexetilFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ATACAND prescribing information (ANI Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Candesartan cilexetil 4 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.